John M Kirkwood

51PUBLICATIONS
395CO-AUTHORS
Predictive and prognostic markersMedical virologyTumour immunologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jun 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|Jun 22, 2026
Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma.

|Jun 19, 2026
Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma.

|Mar 18, 2026
Impact of GM-CSF and Two-Site Vaccination on Clinical Outcomes after Multipeptide Vaccination for Melanoma: Long-term Analysis of a Randomized Phase II Trial.

Emily K Ninmer, Hong Zhu, Amrita Sarkar

|Dec 10, 2025
Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.

Matthias Brand, Juraj Adamik, Hong Wang

Pageof 9

Frequent Collaborators

9 joint publications

Georgina V Long

7 joint publications

Paolo A Ascierto

6 joint publications

Anthony R Cillo

5 joint publications

Dario A A Vignali